ANAPTYSBIO INC (ANAB) Stock Analyst Ratings
NASDAQ:ANAB - Nasdaq - US0327241065 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to ANAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.11. This target is 113.91% above the current price.
ANAB was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ANAB.
In the previous month the buy percentage consensus was at a similar level.
ANAB was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-12 | Guggenheim | Maintains | Buy -> Buy |
| 2024-12-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-11 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-12-02 | BTIG | Downgrade | Buy -> Neutral |
| 2024-11-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | UBS | Maintains | Neutral -> Neutral |
| 2024-10-21 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-26 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-15 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-19 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-05-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-16 | Leerink Partners | Initiate | Outperform |
| 2024-04-11 | Wells Fargo | Initiate | Overweight |
| 2024-04-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-03-12 | Wedbush | Upgrade | Neutral -> Outperform |
| 2024-02-26 | BTIG | Initiate | Buy |
| 2024-02-21 | Stifel | Initiate | Buy |
| 2024-02-16 | Piper Sandler | Initiate | Overweight |
| 2023-11-29 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-11-03 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-11-02 | UBS | Maintains | Neutral -> Neutral |
| 2023-08-08 | Wedbush | Maintains | Neutral -> Neutral |